Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07173192
Enrolling by invitation Not applicable

The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients

NCT07173192 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-05-15
Last updated
2025-09-15

Condition(s) studied

Schizophrenia

Investigational drug(s) / intervention(s)

Individual empowerment program

Individual empowerment program: Data collection tools will be applied to individuals in the experimental and control groups as a pre-test. Individual empowerment training sessions will be applied to individuals in the experimental group totaling (6 sessions) as part of the individual empowerment program. No intervention will be performed on individuals in the control group; they will receive standard discharge education. Data collection tools will be applied to individuals in both groups for post-tests immediately after the experimental group completes all individual empowerment program sessions.

Study summary

Psychoeducation provided to family members caring for individuals with schizophrenia. Has been found to positively impact caregivers' psychological well-being and the effective management of schizophrenia patients.However, further experimental studies are recommended in this area, along with support for caregivers' psychological well-being. Primary caregivers, which includes both psychoeducation and applications aimed at developing coping skills, on the care burden, psychological well-being,and self-efficacy. Considering the gaps in the literature, the aim of this study is to evaluate the effect of an individual empowerment program applied to primary caregivers of patients diagnosed with schizophrenia on the burden of care, psychological well-being, and self-efficacy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: Being the primary caregiver of a patient diagnosed with schizophrenia and other psychotic disorders Volunteering to participate in the study Being 18 years of age or older Being literate Not having a psychiatric illness (diagnosis) Not having a serious mental or physical disorder that prevents communication Exclusion Criteria: Providing care to patients with severe organic brain syndrome such as alcohol or substance dependence, intellectual disability, dementia, or delirium, or with a previous or current general medical condition that could impair cognitive function Withdrawal from the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Arel University Istanbul Cevizlibağ

More Istanbul Arel University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07173192 on ClinicalTrials.gov ↗ ← All trials in Turkey